Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate
15. November 2021 07:00 ET
|
Emergex Vaccines Holding Ltd
PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...
Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate
15. November 2021 02:00 ET
|
Emergex Vaccines Holding Ltd
PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...